{
    "2021-09-17": [
        [
            {
                "time": "",
                "original_text": "人福医药：控股股东解质176万股，占总股本0.11%",
                "features": {
                    "keywords": [
                        "人福医药",
                        "控股股东",
                        "解质",
                        "176万股",
                        "总股本",
                        "0.11%"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "人福医药(600079.SH)控股股东解除质押176万股",
                "features": {
                    "keywords": [
                        "人福医药",
                        "600079.SH",
                        "控股股东",
                        "解除质押",
                        "176万股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "人福医药：注射用苯磺酸瑞马唑仑获批临床试验",
                "features": {
                    "keywords": [
                        "人福医药",
                        "注射用",
                        "苯磺酸瑞马唑仑",
                        "获批",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}